{"id":"nitroglycerin-ii","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Headache"},{"rate":"5-10","effect":"Dizziness"},{"rate":"5-15","effect":"Hypotension"},{"rate":"5-10","effect":"Tachycardia"},{"rate":"5-10","effect":"Flushing"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Nitroglycerin is a prodrug that is bioconverted to nitric oxide (NO), a potent vasodilator. NO activates soluble guanylate cyclase, increasing intracellular cGMP concentrations, which leads to smooth muscle relaxation and vasodilation. This reduces preload and afterload on the heart, improving coronary blood flow and reducing myocardial oxygen demand.","oneSentence":"Nitroglycerin releases nitric oxide, which activates guanylate cyclase to increase cGMP levels, causing vasodilation of blood vessels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:23:09.332Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute angina pectoris"},{"name":"Chronic stable angina"},{"name":"Heart failure with reduced ejection fraction"}]},"trialDetails":[{"nctId":"NCT03135769","phase":"PHASE2","title":"Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2017-02-21","conditions":"Gestational Trophoblastic Neoplasias (GTN)","enrollment":24},{"nctId":"NCT02966665","phase":"PHASE1","title":": Vascular Function in Health and Disease","status":"RECRUITING","sponsor":"Russell Richardson","startDate":"2008-09","conditions":"Chronic Obstructive Pulmonary Disease, Pulmonary Artery Hypertension, Heart Failure","enrollment":420},{"nctId":"NCT05741229","phase":"NA","title":"The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborns","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-01-01","conditions":"Persistent Pulmonary Hypertension of the Newborn, Echocardiography, Respiratory Disease","enrollment":80},{"nctId":"NCT06020755","phase":"PHASE2","title":"Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-12","conditions":"Gestational Trophoblastic Neoplasia","enrollment":17},{"nctId":"NCT03158532","phase":"PHASE3","title":"Prevention of Radial Artery Occlusion After Transradial Access Using Nitroglycerin","status":"COMPLETED","sponsor":"Instituto de Cardiologia de Santa Catarina","startDate":"2017-07-06","conditions":"Injury of Radial Artery","enrollment":2040},{"nctId":"NCT04396223","phase":"PHASE1, PHASE2","title":"Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2020-02-12","conditions":"Gestational Trophoblastic Neoplasias (GTN)","enrollment":26},{"nctId":"NCT06210217","phase":"EARLY_PHASE1","title":"Effect of TEE-guided Non-fluid Limited Combined With Dobutamine on Hepatic Venous Blood Flow Spectrum","status":"UNKNOWN","sponsor":"Sichuan University","startDate":"2024-02-01","conditions":"Laparoscopic Hepatectomy","enrollment":51},{"nctId":"NCT05393557","phase":"NA","title":"Upfront Premedication For Reduction of Microvascular Obstruction and No-reflow in Treating ST-segment Elevation Myocardial Infarction","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2024-01-01","conditions":"STEMI, Large Thrombus Burden, No-Reflow Phenomenon","enrollment":626},{"nctId":"NCT05203562","phase":"PHASE2, PHASE3","title":"Letrozole as a Prophylaxis From GTN for Complete Mole Patients","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2020-06-01","conditions":"Gestational Trophoblastic Disease","enrollment":200},{"nctId":"NCT05446116","phase":"NA","title":"Transfemoral Versus Transradial Partial Splenic Artery Embolization in Patients With Hypersplenism","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2019-06-01","conditions":"Hypersplenism","enrollment":112},{"nctId":"NCT04812002","phase":"PHASE2","title":"Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy","status":"RECRUITING","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2021-04-15","conditions":"Gestational Trophoblastic Neoplasia","enrollment":20},{"nctId":"NCT01171170","phase":"PHASE2","title":"Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Dutch Society of Physicians for Pulmonology and Tuberculosis","startDate":"2011-01","conditions":"Non Small Cell Lung Cancer","enrollment":223},{"nctId":"NCT04014010","phase":"","title":"Machine Learning Modeling of Intraoperative Hemodynamic Predictors of Postoperative Outcomes","status":"COMPLETED","sponsor":"Janny Xue Chen Ke","startDate":"2013-01-01","conditions":"Perioperative/Postoperative Complications, Morbidity, Multiple, Surgery","enrollment":35000},{"nctId":"NCT04338867","phase":"PHASE2","title":"Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients","status":"COMPLETED","sponsor":"Instituto Nacional de Cancerologia de Mexico","startDate":"2020-03-01","conditions":"Phase II Clinical Trial, Ninety-six Histologically Confirmed NSCLC Patients With BM, Randomized 1:1 to Received TN Plus WBR or Only WBR","enrollment":96},{"nctId":"NCT03569046","phase":"NA","title":"General Anesthesia With or Without Local Ear Block in Middle Ear Surgeries","status":"COMPLETED","sponsor":"Abd-Elazeem Abd-Elhameed Elbakry","startDate":"2018-07-06","conditions":"Tympanum; Perforation","enrollment":80},{"nctId":"NCT01210378","phase":"PHASE2","title":"Nitroglycerin in Non-small Cell Lung Cancer","status":"TERMINATED","sponsor":"Maastricht Radiation Oncology","startDate":"2011-12","conditions":"Non Small Cell Lung Cancer (NSCLC)","enrollment":47},{"nctId":"NCT03422913","phase":"NA","title":"Controlled Low Central Venous Pressure Combined With Hilar Block in Laparoscopic Hepatectomy","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2017-07-01","conditions":"Laparoscopic Hepatectomy","enrollment":140},{"nctId":"NCT03404037","phase":"","title":"Serum Endostatin Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2017-03-02","conditions":"Diabetes Mellitus, Type 2, Coronary Artery Disease, Coronary Arteriosclerosis","enrollment":110},{"nctId":"NCT02344602","phase":"PHASE4","title":"The Effect of Uric Acid Lowering in Type 1 Diabetes","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2012-12-18","conditions":"Type 1 Diabetes Mellitus","enrollment":73},{"nctId":"NCT01969084","phase":"PHASE4","title":"The Effect of Linagliptin on Mitochondrial and Endothelial Function","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2013-10","conditions":"Type II Diabetes Mellitus","enrollment":45},{"nctId":"NCT01631409","phase":"","title":"Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy","status":"WITHDRAWN","sponsor":"City Hospital No 40, Saint Petersburg, Russia","startDate":"2013-09","conditions":"Coronary Heart Disease (CHD)","enrollment":""},{"nctId":"NCT00616031","phase":"PHASE2","title":"Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer","status":"UNKNOWN","sponsor":"Kyoto University","startDate":"2008-01","conditions":"Lung Cancer","enrollment":150},{"nctId":"NCT00998439","phase":"PHASE2","title":"Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter","status":"UNKNOWN","sponsor":"Klinikum Coburg","startDate":"2009-10","conditions":"In-Stent Restenosis","enrollment":120},{"nctId":"NCT00886405","phase":"PHASE2","title":"Concurrent Chemotherapy and Radiotherapy With Nitroglycerin in Patients With Locally Advanced Non-Small Cell Lung Cancer","status":"UNKNOWN","sponsor":"National Institute of Cancerología","startDate":"2006-07","conditions":"Locally Advanced Non Small-Cell Lung Canger","enrollment":40},{"nctId":"NCT00641953","phase":"PHASE2","title":"IMX-150 Cream for Diabetic Neuropathy","status":"COMPLETED","sponsor":"Procris Pharmaceuticals","startDate":"2007-08","conditions":"Diabetic Peripheral Neuropathy","enrollment":155},{"nctId":"NCT00480753","phase":"PHASE2","title":"Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon","status":"COMPLETED","sponsor":"MediQuest Therapeutics","startDate":"2007-05","conditions":"Raynaud's Disease","enrollment":15},{"nctId":"NCT00378521","phase":"PHASE2","title":"Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon","status":"COMPLETED","sponsor":"MediQuest Therapeutics","startDate":"2006-07","conditions":"Raynaud's Disease, Raynaud's Disease Secondary to Scleroderma, Raynaud's Disease Secondary to Autoimmune Disease","enrollment":15},{"nctId":"NCT00447928","phase":"PHASE2","title":"Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow","status":"UNKNOWN","sponsor":"Cure Therapeutics","startDate":"2007-04","conditions":"Tendonitis","enrollment":164}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Tridil"],"phase":"phase_3","status":"active","brandName":"Nitroglycerin II","genericName":"Nitroglycerin II","companyName":"Instituto de Cardiologia de Santa Catarina","companyId":"instituto-de-cardiologia-de-santa-catarina","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nitroglycerin releases nitric oxide, which activates guanylate cyclase to increase cGMP levels, causing vasodilation of blood vessels. Used for Acute angina pectoris, Chronic stable angina, Heart failure with reduced ejection fraction.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}